MRI Monitoring Alone Benefits Cognitive Function in Small Cell Lung Cancer Patients

Mejora en la supervivencia sin deterioro cognitivo Un enfoque de vigilancia mediante MRI cerebral sin radioterapia craneal profiláctica (PCI) mostró mejorar la supervivencia libre de fallo cognitivo (CFFS) en pacientes con cáncer de pulmón de células pequeñas (SCLC), según el estudio de fase III conocido como MAVERICK. Los pacientes que fueron asignados aleatoriamente a la […]

Escasez de Fármacos Oncológicos: Un Problema Persistentemente Urgente

Según una encuesta anual, todos los miembros de la Red Nacional Integral del Cáncer (NCCN) que respondieron reportaron escasez de fármacos quimioterapéuticos genéricos comúnmente utilizados, destacando el ifosfamida, que estuvo críticamente escaso en casi todos los centros. Graves Consecuencias de la Escasez Las respuestas de los directores de farmacia y el liderazgo clínico de los […]

IVIG Shows Promising Results as Therapy for Inflammatory Myopathies

Patients diagnosed with idiopathic inflammatory myopathies (IIMs), such as dermatomyositis, exhibited greater improvement when treated with intravenous immunoglobulin (IVIG) in conjunction with prednisone compared to those who received only the steroid in a placebo-controlled randomized trial. Study Findings The Total Improvement Score (TIS), derived from six measures of IIM disease activity, rose by an average […]

Approval of First Therapy to Counteract Muscle Loss in Spinal Muscular Atrophy

Introduction The FDA has granted approval for apitegromab (Isembyld) injection, designed to treat spinal muscular atrophy (SMA) in both adults and pediatric patients aged 2 years and older who are currently receiving treatment targeting the SMN2 gene. This announcement was made by the agency recently. This drug marks the first therapy approved specifically for SMA […]

Comparison of Two-Drug and Three-Drug Regimens for Untreated HIV Patients

Resumen del Estudio Un régimen de dos fármacos ha mostrado ser no inferior a un régimen de tres fármacos como terapia antirretroviral inicial (ART) para adultos con VIH, según un ensayo de fase IIIb. Al final de 48 semanas, un nivel de ARN del VIH-1 inferior a 50 copias/mL fue alcanzado por el 89% de […]

New Weekly HIV Treatment Option Shows Comparable Efficacy to Daily Regimens

Switching to a weekly oral investigational regimen of islatravir and lenacapavir (Sunlenca) was just as effective as daily oral standard-of-care regimens in patients with virologically suppressed HIV, according to two phase III trials. ISLEND-1 Trial Results In the double-blind ISLEND-1 trial, 93.4% of patients who switched from once-daily, single-tablet bictegravir, emtricitabine, and tenofovir alafenamide (Biktarvy) […]

High Discontinuation Rates of Semaglutide for Obesity Management

According to a recent Danish cohort study, nearly half of adults who initiated semaglutide (Wegovy) for obesity management discontinued treatment within a year. Discontinuation Rates Among 157,822 first-time semaglutide users without diabetes, 49% stopped treatment by 12 months, indicated by a prescription gap of 60 days or more. The discontinuation rates increased steadily, starting from […]

Increased Risks of Gallbladder Issues Linked to GLP-1 Drugs in Young Individuals

El uso de agonistas del receptor GLP-1 se asoció con un aumento de eventos acumulativos de la vesícula biliar y biliares en jóvenes, según un análisis retrospectivo de datos de TriNetX. Entre más de 37,000 adolescentes y jóvenes adultos con sobrepeso u obesidad, el uso de medicamentos GLP-1 se asoció con riesgos incrementados de cólico […]

New Findings Support Shorter Antibiotic Treatment for Infective Endocarditis

Shorter antibiotic treatment worked better in clinically stabilized patients with infective endocarditis on the left side of the heart, even though the risk of infection relapse may be greater, according to the open-label randomized POET II trial. After a minimum of 2-4 weeks to achieve clinical stability, those randomized to cease antibiotic treatment (tailored approach) […]

Innovative Monitoring Device Provides Insights for Unexplained Fainting Cases

Para las personas que acuden a departamentos de emergencia (ED) por síncope, un protocolo de monitoreo de ECG extendido hizo que un diagnóstico eventual fuera más probable, aunque la frecuencia de desmayos no cambió, de acuerdo con el ensayo ASPIRED. A través de varios hospitales en el Reino Unido, se aleatorizó a personas con síncope […]

Cargando